
Hims & Hers Health, Inc.
NYSE:HIMSLive AI agent
Hims & Hers is a digital health platform founded in 2017 that connects people to licensed healthcare providers and personalized treatment plans.
Investor website: https://hims.com/
About
Hims & Hers is a digital health platform founded in 2017 that connects people to licensed healthcare providers and personalized treatment plans. The company focuses on normalizing health and wellness challenges, providing access to care across various areas including sexual health, hair care, weight loss, and mental health. Hims & Hers aims to empower customers with personalized care designed for results, ensuring ongoing clinical support and educational resources.
Verified company data
- Leadership
- Andrew Dudum (CEO, Co-founder of Hims & Hers, entrepreneur with a passion for innovation and accessibility, previously co-founded Atomic Labs.), Soleil Boughton (Chief Legal Officer, Over 20 years of healthcare law experience, previously held positions at Google Cloud Healthcare & Life Sciences.), Yemi Okupe (Chief Financial Officer, Extensive financial leadership experience from high-growth B2C companies including Uber, eBay, PayPal, and Google.), Mike Chi (Chief Commercial Officer, Over 20 years of experience in consumer-focused businesses, expertise in brand positioning and growth marketing.), Patrick Carrol, MD (Chief Medical Officer, Extensive leadership in virtual and retail healthcare, oversees care delivery and clinical outcomes.), Dan Kenger (Chief Design Officer, Over 15 years of experience leading creative teams, previously served as VP of Creative at Pattern Brands.), Mo Elshenawy (Chief Technology Officer, Over 20 years of experience in AI and large-scale infrastructure, previously President and CTO at Cruise.), Dheerja Kaur (Chief Product Officer, Nearly 20 years of experience building consumer-focused products, previously held leadership roles at Robinhood and The Skimm.)
Verified data last updated:
Recent filings
- Notice of proposed sale of securities pursuant to Rule 144 · hims_2026-10-01_15-05-54.pdf
- Notice of proposed sale of securities pursuant to Rule 144 · hims_2026-09-30_13-31-09.pdf
- Statement of changes in beneficial ownership of securities · hims_2026-09-23_19-17-12.pdf
- Notice of proposed sale of securities pursuant to Rule 144 · hims_2026-09-22_15-12-44.pdf
- Statement of changes in beneficial ownership of securities · hims_2026-09-18_19-17-22.pdf
- Notice of proposed sale of securities pursuant to Rule 144 · hims_2026-09-17_18-55-12.pdf
- Notice of proposed sale of securities pursuant to Rule 144 · hims_2026-09-16_13-05-05.pdf
- Notice of proposed sale of securities pursuant to Rule 144 · hims_2026-09-15_13-14-32.pdf